Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Incyte licenses RNA amplification technology and related patent

March 27, 1998

FDA advisory committee recommends expanded labeling for CEPRATE SC System

March 26, 1998

Ribozyme, Parke-Davis collaboration confirmed

March 25, 1998

Progenitor, CAT establish gene-to-clinic collaboration

March 25, 1998

T7T7 increases efficacy of cancer gene therapy in preclinical studies

March 24, 1998

Progress made in Lilly/Emisphere protein delivery collaboration

March 20, 1998

LifeCell will be awarded U.S. patent for blood cell preservation technology

March 19, 1998

Morphogenesis awarded phase I SBIR grant

March 18, 1998

SangStat and Dyax enter license agreement

March 17, 1998

Cornerstone patent awarded to Hyal

March 16, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...